- 2024-08-20 02:11抑制剂SB 415286|SB 415286|264218-23-7|Adamas life|≥99%（以实测数值为准）|BR|5mg
- 2024-08-20 02:11抑制剂SB 218795|SB 218795|174635-53-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:11抑制剂SB 218795|SB 218795|174635-53-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:11抑制剂SB 218795|SB 218795|174635-53-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:11抑制剂SB 415286|SB 415286|264218-23-7|Adamas life|≥99%（以实测数值为准）|BR|100mg
- 2024-08-20 02:11抑制剂SAR-020106|SAR-020106|1184843-57-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:11抑制剂SB 202190|SB 202190|152121-30-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:11抑制剂SB 202190|SB 202190|152121-30-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:11抑制剂SB 202190|SB 202190|152121-30-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:11抑制剂Sapacitabine|Sapacitabine|151823-14-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:11抑制剂SAR-020106|SAR-020106|1184843-57-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:11抑制剂SAR-020106|SAR-020106|1184843-57-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:11抑制剂Samuraciclib|Samuraciclib|1805833-75-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:11抑制剂Samuraciclib|Samuraciclib|1805833-75-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:11抑制剂Sapacitabine|Sapacitabine|151823-14-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:11抑制剂Sapacitabine|Sapacitabine|151823-14-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:11抑制剂Samuraciclib hydrochloride|Samuraciclib hydrochloride|1805789-54-1|Adamas life|≥98%（以实测数值为准）|BR|1
- 2024-08-20 02:11抑制剂Samuraciclib hydrochloride|Samuraciclib hydrochloride|1805789-54-1|Adamas life|≥98%（以实测数值为准）|BR|2
- 2024-08-20 02:11抑制剂Samuraciclib hydrochloride|Samuraciclib hydrochloride|1805789-54-1|Adamas life|≥98%（以实测数值为准）|BR|5
- 2024-08-20 02:11抑制剂Safimaltib|Safimaltib|2230273-76-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
